Differences in HCV Viral Decline between Low and Standard-Dose Pegylated-Interferon-Alpha-2a with Ribavirin in HIV/HCV Genotype 3 Patients

BACKGROUND: The aim of the study was to analyze the different impact of standard and low-dose Peg-IFN-α2a/RBV therapies on HCV viral decline in HIV/HCV genotype 3 co-infected patients during the first weeks of treatment. METHODS: Plasma HCV viral decline was analyzed between baseline and weeks 1, 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Rivero-Juárez, Antonio, Lopez-Cortes, Luis F., Camacho, Angela, Torres-Cornejo, Almudena, Pineda, Juan A., Marquez-Solero, Manuel, Caruz, Antonio, Ruiz-Valderas, Rosa, Torre-Cisneros, Julian, Gutierrez-Valencia, Alicia, Rivero, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493612/
https://www.ncbi.nlm.nih.gov/pubmed/23145040
http://dx.doi.org/10.1371/journal.pone.0048959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493612/
https://www.ncbi.nlm.nih.gov/pubmed/23145040
http://dx.doi.org/10.1371/journal.pone.0048959

Ejemplares similares